GI Pharmacology Course

Medical Therapies for Crohn's Disease: What to Start With and When to Change

Speaker(s)

• 

  Millie Long, MD, MPH, FACG

  Associate Professor of Medicine
  University of North Carolina, Center for Gastrointestinal Biology and Disease
  Chapel Hill, NC, US

  Advisory Committee/Board Member: AbbVie, Janssen, Pfizer, Prometheus, Takeda, UCB, Inc.
  Consultant: AbbVie, Pfizer, Prometheus, Salix, Takeda, Target PharmaSolutions, Theravance, UCB, Inc.
  Grant/Research Support: Pfizer, Takeda, Theravance
  

Learning Objectives:

• Describe the evidence for when to employ different medical therapies available for Crohn's disease and review algorithms for altering medical management when necessary.